[Rinsho ketsueki] The Japanese journal of clinical hematologyHumansImmunityInnateImmunotherapyTumor Microenvironment
[Myeloid tumors and antitumor innate immunity].
Susumu Goyama
Published: 202510.11406/rinketsu.66.883
Abstract
The success of immune checkpoint inhibitors and CAR-T cell therapies has established immunotherapy as the "fourth pillar" of cancer treatment, alongside surgery, radiation, and chemotherapy. However, the therapeutic efficacy of immunotherapy for myel…
Preview only. Read the full abstract at the source